推荐产品
1 of 4
此商品 | 299693 | 638560 | 843951 |
|---|---|---|---|
| assay 98% | assay 98% | assay 97% | assay - |
| density 1.259 g/mL at 25 °C (lit.) | density 1.143 g/mL at 25 °C (lit.) | density 1.148 g/mL at 25 °C (lit.) | density 1.259 g/cm3 at 25 °C |
| form liquid | form liquid | form - | form liquid |
| refractive index n20/D 1.471 (lit.) | refractive index n20/D 1.467 (lit.) | refractive index n20/D 1.4470 (lit.) | refractive index - |
| bp 105-107 °C/2 mmHg (lit.) | bp 166 °C/18 mmHg (lit.) | bp 76 °C/0.8 mmHg (lit.) | bp - |
| Quality Level 200 | Quality Level 200 | Quality Level 100 | Quality Level 200 |
一般描述
Degradex®采用聚（D,L-丙交酯-共-乙交酯）制成，L/G比为50/50，分子量为30,000。
复溶：
复溶：
- 从冰柜中取出产品。
- 等待温度升至环境温度。
- 向容器中加入去离子水或缓冲液。
- 涡旋并超声处理5分钟，以确保微球充分混悬。
应用
法律信息
Degradex is a registered trademark of Phosphorex, Inc.
相关产品
产品编号
说明
价格
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
Kwon HY, et al.
Colloids and Surfaces. A, Physicochemical and Engineering Aspects, 182(1-3), 123-130 (2001)
The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers
Qaddoumi MG, et al.
Pharmaceut. Res., 21(4), 641-648 null
商品
Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.
Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.
Biomaterials science integrates smart materials into biological research, requiring a deep understanding of biological systems.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
